ProShare Advisors
ORIC icon

ProShare Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

ProShare Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178K Sell
14,079
-2,313
-14% -$26.3K ﹤0.01% 1617
2025
Q4 		$134K Buy
16,392
+3,009
+22% +$34.6K ﹤0.01% 1816
2025
Q3 		$161K Buy
13,383
+1,527
+13% +$16.1K ﹤0.01% 1751
2025
Q2 		$120K Sell
11,856
-4,675
-28% -$31.4K ﹤0.01% 1841
2025
Q1 		$92.2K Sell
16,531
-4,152
-20% -$36.3K ﹤0.01% 1850
2024
Q4 		$167K Buy
20,683
+4,881
+31% +$44.8K ﹤0.01% 1940
2024
Q3 		$162K Buy
+15,802
New +$156K ﹤0.01% 1783
2024
Q2 		– Sell
-11,733
Closed -$161K – 1957
2024
Q1 		$161K Buy
+11,733
New +$139K ﹤0.01% 1725
2022
Q1 		– Sell
-12,447
Closed -$184K – 2273
2021
Q4 		$184K Sell
12,447
-2
-0% -$31 ﹤0.01% 2065
2021
Q3 		$260K Sell
12,449
-1,869
-13% -$37.9K ﹤0.01% 1647
2021
Q2 		$253K Buy
14,318
+3,187
+29% +$69.8K ﹤0.01% 2000
2021
Q1 		$273K Buy
11,131
+562
+5% +$17.8K ﹤0.01% 1858
2020
Q4 		$358K Buy
+10,569
New +$303K ﹤0.01% 1494

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return